Sponsored Content
Cardiometabolic Diseases Linked With Increased Dementia RIsk For Younger, Female Patients
Patients with a single cardiometabolic disease have an approximate 48% greater risk of developing all-cause dementia compared with those without a cardiometabolic disease.
The Opportunities, Gaps in Diabetes Care Making Pharmacists Stand Out | ADA 2025
Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.
Once Weekly Insulin Efsitora Alfa Shows Similar Efficacy to Daily Insulin
Efsitora demonstrates noninferior reductions in hemoglobin A1c and similar rates of patients with an A1c of less than 7% compared with common daily insulin.
Wicked Good Cardiometabolic Chat: Compounded Weight Loss Medications
In the first episode of the podcast, Jennifer Goldman and Hailey Choi discuss the latest FDA updates around compounded weight loss medications, clinical concerns and how pharmacists can protect their patients.
GLP-1s Effective as Adjunctive Therapy in Patients with T1D, Obesity | ADA 2025
Researchers explored patients with type 1 diabetes and overweight or obesity to understand the efficacy and safety of GLP-1s as adjunctive therapies.
Q&A: The Evolving Role Pharmacists Play in Team-Based Diabetes Care | ADA 2025
In a recap of his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter, RPh, discussed the role of pharmacists in team-based diabetes care.
